Delivery Order SPE2DE21D7010-SPE2D626F943A
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order on November 3, 2025, for RELINE MAS IMPLANTS with a ceiling value of $22,376.93 and an ultimate completion date of November 24, 2025. This fixed-price contract with economic price adjustment was issued without set-aside designation by the Defense Logistics Agency Medical Supply Chain, a component of the Department of Defense responsible for procuring medical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $15,124.90 on November 12, 2025, for RELINE MAS IMPLANTS under contract number 4569992779. The contract utilizes fixed-price pricing with economic price adjustment mechanisms and carries an ultimate completion date of December 3, 2025. This delivery order was issued without set-aside designation through the Defense Logistics Agency Medical Supply...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, received a $15,686.10 delivery order award from the Defense Logistics Agency (DLA) Medical Supply Chain on June 17, 2025, for RELINE MAS implants. The contract utilizes a fixed-price structure with economic price adjustment provisions and has an ultimate completion date of June 18, 2025. This award was made without set-aside designation, reflecting Nuvasive's competitive success in open...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products and implants, was awarded a $12.43K fixed-price delivery order with economic price adjustment for RELINE MAS IMPLANTS by the Defense Logistics Agency (DLA) Medical Supply Chain on September 9, 2025. The contract, with an ultimate completion date of October 3, 2025, carries no set-aside designation, indicating open market competition. Performance will take place in San Diego, California. This delivery...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,646.10 fixed-price delivery order (Contract #4570184048) on December 2, 2025, for RELINE OPEN IMPLANTS. This delivery order, issued without set-aside designation, is funded through the Defense Logistics Agency Medical Supply Chain and includes an economic price adjustment mechanism to address cost fluctuations. Performance is scheduled for completion by December 3,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,607.94 fixed-price delivery order (contract number 4570040417) by the Defense Logistics Agency Medical Supply Chain on November 13, 2025, for RELINE OPEN IMPLANTS to be delivered by December 5, 2025. The contract was awarded without set-aside designation through open market competition and includes an economic price adjustment mechanism to accommodate cost fluctuations....
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products, received a delivery order award from the Defense Logistics Agency (DLA) Medical Supply Chain for RELINE MAS implants valued at $11,751.69. The contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a fixed-price with economic price adjustment pricing structure and includes no set-aside designation, indicating open market competition. This delivery order...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $47,148.17 for RELINE MAS IMPLANTS on July 22, 2025. The contract utilizes a fixed-price with economic price adjustment pricing structure and carries no set-aside designation, indicating open market competition. The work will be performed in San Diego, California, with an ultimate completion date of August 15, 2025. This delivery order is funded by the...
- Nuvasive, Inc. was awarded a delivery order valued at $12,607.94 by the Defense Logistics Agency Medical Supply Chain on June 26, 2025, for the procurement of RELINE open implants. The contract, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by July 17, 2025, and will be performed at Nuvasive's San Diego, California location. This award was made through open competition with no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc. was awarded a $13,808.82 fixed-price delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain on October 14, 2025, for the procurement of RELINE MAS implants, with performance scheduled to conclude by November 3, 2025. The award was made without a set-aside designation, indicating open competition. The contract utilizes a fixed-price structure with economic price adjustment mechanisms, supporting the delivery of specialized spinal medical technology to federal...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F943ADelivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $4,682.23 on December 5, 2025, for RELINE MAS IMPLANTS through the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of December 30, 2025. No set-aside designation was used in this competitive procurement. Performance will be conducted at Nuvasive's facility in San Diego, California, with the products destined for Department of Defense and Department of Veterans Affairs healthcare facilities. This delivery order is issued under Nuvasive's established federal contract portfolio with the DLA Medical Supply Chain, which has consistently procured specialized spinal surgical technologies and implants from the company. The award also benefits from Nuvasive's participation in a larger $8 million Blanket Purchase Agreement (BPA) with the Defense Health Agency structured as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle effective through March 2027, which streamlines procurement of the company's comprehensive spinal device portfolio across military and veteran healthcare systems. RELINE MAS IMPLANTS represents one of Nuvasive's core product offerings for advanced spinal surgical procedures, supporting the medical readiness and surgical capabilities of federal healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 12/4/25 |